FDA advisors review Alzheimer’s drug Leqembi for full approval FDA Panel Meets to Discuss Full Approval of Alzheimer’s Drug Leqembi A panel of independent advisors… Đọc tiếp »FDA Experts Assess the Feasibility of Granting Full Approval to Alzheimer’s Drug Leqembi
Lawmakers press for more info on Medicare coverage Democratic Lawmakers Demand More Information on Medicare’s Coverage Plan for Alzheimer’s Treatments Democratic lawmakers Rep. Anna Eshoo… Đọc tiếp »Lawmakers demand greater clarity about Medicare coverage.
Merck sues Biden administration over Medicare drug price negotiations Drug manufacturer Merck has filed a lawsuit against the Biden administration over Medicare’s new powers to… Đọc tiếp »Biden Administration Faces Lawsuit from Merck for Medicare Drug Price Negotiations
FDA allows import of unapproved China chemo med In response to an acute shortage of cancer drugs in the United States, the US Food and… Đọc tiếp »Unapproved Chinese Chemotherapy Medication Now Allowed for Import by FDA
ASCO will focus on the cancer fight. These stocks are in the spotlight The American Society of Clinical Oncology will be hosting the world’s biggest… Đọc tiếp »Cancer battle to be the main focus at ASCO: Check out the stocks in the limelight.
Illumina shareholders oust board chair in Carl Icahn proxy battle Carl Icahn, an activist investor, has succeeded in ousting Illumina’s board chair after obtaining enough… Đọc tiếp »Board chair removed by Illumina shareholders during proxy fight with Carl Icahn.
Fund manager says there’s investment opportunities in femtech Investors are being urged to consider the underrepresented sector of women’s healthcare, according to fund manager Philip… Đọc tiếp »Femtech presents attractive investment prospects, according to fund manager
Pfizer weight loss drug compares to Ozempic by Novo Nordisk Pfizer’s oral weight-loss drug, danuglipron, has proven to be as effective as rival Novo Nordisk’s… Đọc tiếp »Comparison of Pfizer’s Weight Loss Medication with Novo Nordisk’s Ozempic